Validation of transcatheter aortic valve implantation (TAVI), an emerging therapeutic option for patients with severe aortic stenosis who cannot undergo valve replacement surgery, hinges on forthcoming results of clinical trials.
Over use of Stents for cardiac coronary heart diseases, has been under the scanner for a few years. In a shocking revelation heartwire news desk brings out this story on an ongoing investigation. “what would we find if we were to examine our Indian scenario where regulations in the field of medicine and cardiology are today strictly based on the consultants idea and not on generalized guidelines”. http://www.medscape.com/viewarticle/723222?src=mpnews&spon=2&uac=101531CK click this link for the original article form Heartwire
Address the impact of positron emission tomography with [18F]fluorodeoxyglucose (PET-FDG) on the initial staging and management of patients with head and neck squamous cell carcinoma (HNSCC).
Using two positron emission tomography (PET) probes, one common one and one they developed themselves, researchers in the US found they can get a much clearer picture of what happens at the cellular level during an immune response…
Validation of transcatheter aortic valve implantation (TAVI), an emerging therapeutic option for patients with severe aortic stenosis who cannot undergo valve replacement surgery, hinges on forthcoming results of clinical trials.
The nuclide bone-scan will reliably diagnose Perthes’ disease with a sensitivity of 0.98 and a specificity of 0.95. The comparable figures for radiographic sensitivity and specificity are respectively 0.92 and 0.78. In addition, it is possible on the scan to recognise the onset of revascularisation of the femoral capital epiphysis some months before there are radiographic signs of new bone formation. Scintigraphy also suggests that in some cases of transient synovitis there may bae a period of reversible ischaemia of the capital epiphysis, which may have relevance to the pathogenesis of Perthes’ disease.
Good news for chocolate fanatics with high blood cholesterol. A little chocolate might help cut cholesterol say’s an article published by Reuters Health on 1st June 2010 at New York. Warning THIS DOES NOT MEAN ANY AMOUNT OF CHOCOLATE IS HELPFUL
May 28, 2010 (Rochester, New York) — A new study has suggested that a raised HDL-cholesterol level, if present in conjunction with a raised C-reactive-protein (CRP) level, may confer increased cardiovascular risk [1]. And that in these patients, reduced cholesteryl-ester-transfer-protein (CETP) activity is associated with even higher risk, giving a potential explanation to the negative findings of the torcetrapib (Pfizer) studies.
Explains how the EECP therapy is used effectively on patients of week health conditions.